- Plus Therapeutics press release (NASDAQ:PSTV): Q4 GAAP EPS of -$4.24 misses by $3.07.
- Revenue of $4.91M.
- Current financial forecast for sufficient runway to fund operations into 2H 2025
Plus Therapeutics GAAP EPS of -$4.24 misses by $3.07
Recommended For You
More Trending News
About PSTV Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| PSTV | - | - |
| Plus Therapeutics, Inc. | ||